Location: Home
  • search
  • go
  • Relate News
  • 10/16/2018Alphamab's HER2 Bispecific Antibody KN026 Gains US IND
  • 10/16/2018CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001
  • 10/16/2018Targeting the Affluent: Differential Access to Targeted Therapies in C...
  • 10/16/2018Changchun Changsheng Biotech Fined CNY 9.1B in Vaccine Scandal
  • 10/15/2018How to Fulfill China’s Potential for Carrying Out Clinical Trials
  • 10/15/2018Innovent Granted Chinese IND for Sintilimab/Bevacizumab Combinaiton Th...
  • 10/15/2018Zheijiang Huahai Placed under Increased Supervision
  • 10/15/2018Exploring Ways to Establish Presence in China as Part of APAC Region P...
  • 10/15/2018NHC Outlines Drug Administrative Policy Directions and Tasks in Nation...
  • 10/12/2018Eisai's NDA for Antiepileptic Drug Perampanel Accepted in China
  • 10/12/2018Mesoblast and Tasly Complete Strategic Cardiovascular Partnership in C...
  • 10/11/2018NEJM and CCA Enter Partnership for CVS Research and Training
  • 10/11/2018MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...
  • 10/11/2018State Council Issues New Document to Reform Licensing Mechanisms
  • 10/10/2018New U.S. Rules on Foreign Investment to Curb Chinese Goldrush in U.S. ...
  • 10/10/2018SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...
  • 10/9/2018Chinese Prof at MD Anderson Cancer Center under Scrutiny for Spying
  • 10/9/2018Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...
  • 10/9/2018China's HIV/AIDS Cases Rise by 14%
  • 10/9/2018China: AstraZeneca’s New Engine for Growth and Innovation
  • 10/9/2018Beigene Teams up With Springworks to Target Advanced Solid Tumors
  • 10/9/2018Listed Chinese Pharma Cos Reports Positive Performance in H1
  • 10/9/2018NHC Reports Higher Health Literacy in China
  • 10/8/2018CDE Solicits Comments on Technical Requirements for Manufacturing Site...
  • 10/8/2018NMPA Issues Rules for Communications Related to Drug R&D and Techn...
  • 10/8/2018Innovent to Start US Trials of Anti-CD47 Cancer Drug
  • 10/8/2018Genscript Denies Fake Data Allegations after Shares Plunge
  • 10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...
  • 10/8/2018Yisheng Biopharma Cleared by NMPA to Proceed with PIKA Rabies Vaccine ...
  • 10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma
  • Page:307/775 Total number of articles:23222: [First][<<] [305] [306] [307] [308] [309] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group